Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.
about
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical UtilityDecreased expression levels of cell cycle regulators and matrix metalloproteinases in melanoma from RET-transgenic mice by single irradiation of non-equilibrium atmospheric pressure plasmas.A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.The clinical response to vemurafenib in a patient with a rare BRAFV600DK601del mutation-positive melanoma.Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced MelanomaCompetitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanomaDabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case reportMutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations.Genetic alterations and personalized medicine in melanoma: progress and future prospects.The use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutation.Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma.Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.Tumour mutation status and sites of metastasis in patients with cutaneous melanoma.Novel BRAF mutation in melanoma: A case report.A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
P2860
Q28078465-4812EC1D-FF15-41FE-925A-45F3C8EAA4A8Q33466341-8AEF1EFB-0EC7-4342-9689-9D39ED16D667Q33875566-A5980F5D-1C7E-4355-A4F9-A9303485F858Q34316552-0FFFCAC5-EF92-42B5-A005-5D23C88C546AQ35725686-72C736CE-DAC6-42B5-A915-7AEB42CAF880Q35885523-A5D325AB-899C-4B1F-9D7C-1445784CFCC8Q35889462-A0EB874B-7813-4AF4-AC57-389ECD2CE3E3Q36392912-228ECFC5-1DBE-472B-A8DA-46C08F9B5204Q36545907-4497102B-8B46-40BF-A933-D47419CA4E19Q36960097-4247190F-A120-4036-BAE6-D0424FA5D862Q37352562-83CA0ACD-A2C4-41DD-96D8-BD93B1431BA5Q38186704-337E76C8-ADD2-458A-8675-E83853DC4089Q38203019-8022028E-AB55-448F-AE13-2A114EFB7B6CQ38994275-20827E4F-27CD-4E81-B894-3A41C1FC7F69Q40087210-A53DBE28-EB3A-4575-8B82-1519C5C5D73BQ41874659-0402124B-6B76-43F8-AC4C-CD2FDAE0869DQ42947925-7B2A71C5-BA98-4A9D-8F1F-6530F18F05C1Q47103823-53A53D12-6D68-4265-B6D5-00A6E7F68E8DQ47978745-F68F8F0D-A697-482F-AF63-ED9C170C889EQ49873933-1C23548F-D6FE-4895-8DF9-9D643A011056Q51595959-4EFFECB7-076E-4505-A09B-D6E4D126FB07Q54386381-13E372EC-6ED7-40D7-9B81-84C5CA1057DEQ54976792-0300EB2B-AFBD-4E4C-B534-EDB3CE96E143
P2860
Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Rare BRAF mutations in melanom ...... testing in clinical practice.
@en
type
label
Rare BRAF mutations in melanom ...... testing in clinical practice.
@en
prefLabel
Rare BRAF mutations in melanom ...... testing in clinical practice.
@en
P2093
P2860
P356
P1476
Rare BRAF mutations in melanom ...... r testing in clinical practice
@en
P2093
A Hartmann
D Meckbach
E Kaempgen
F Kiesewetter
L Heinzerling
P Keikavoussi
R Schneider-Stock
P2860
P2888
P304
P356
10.1038/BJC.2013.143
P407
P50
P577
2013-04-11T00:00:00Z